Agenus Inc.

Halal Rating :
See Details
Last Price $6.50 Last updated:
Market Cap $214.49m
7D Change -30.24%
1 Year Change 347.93%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date March 14, 2024

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $83.7m $136.48m - $44.57m 0.00% 32.66%
Sept. 30, 2023 $24.31m $89.29m - $18.63m 0.00% 20.87%
June 30, 2023 $25.3m $99.6m - $19.65m 0.00% 19.73%

Company Impact

Help us evaluate Agenus Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates